Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

SMC Update - November 2016

The Scottish Medicines Consortium (SMC) has issued its monthly advice on newly licensed medicines.

Dequalinium (Fluomizin®) has been accepted for restricted use in the treatment of bacterial vaginosis where the initial treatment is ineffective or not well tolerated.

Action: Clinicians should be aware of the recommendations of the SMC. Routine use of rejected and restricted medicines should be avoided.

Share 'SMC Update - November 2016' on Email Share 'SMC Update - November 2016' on Delicious Share 'SMC Update - November 2016' on Digg Share 'SMC Update - November 2016' on Facebook Share 'SMC Update - November 2016' on Google+ Share 'SMC Update - November 2016' on reddit Share 'SMC Update - November 2016' on StumbleUpon Share 'SMC Update - November 2016' on Twitter

atomic-wealth

No Comments to “SMC Update - November 2016”

Leave a Comment

(required)

(required)


Prescribing Advice for GPs is powered by WordPress.
Subscribe for Free to our RSS or Atom Feeds for New Entries.
Akismet has protected Prescribing Advice for GPs from 789,518 spam comments.

atomic-wealth
fond-illness
summer